22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522753974/en/Verastem-Oncology-Announces-Positive-Updated-Results-from-RAMP-205-Evaluating-Avutometinib-Plus-Defactinib-in-Combination-with-Standard-of-Care-Chemotherapy-in-Frontline-Metastatic-Pancreatic-Ductal-Adenocarcinoma
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079541/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-AVMAPKI-FAKZYNJA-CO-PACK.html
09 May 2025
// ENDPTS
https://endpts.com/verastem-wins-first-fda-approval-for-ovarian-cancer-therapy/
13 Jan 2025
// BUSINESSWIRE
30 Dec 2024
// BUSINESSWIRE
31 Oct 2024
// BUSINESSWIRE